A quick glance at the historical trajectory of malaria research reveals that it has been embedded in a larger context of gender bias in medical research. During the clinical development of most new medicines, including antimalarial drugs, pregnant people are actively excluded from trials. Fortunately, there is now growing determination within the malaria community to rectify gender-related data gaps.
Head of Product Development
Wiweka Kaszubska is Head of Product Development at that Medicines for Malaria Venture, a leading product development partnership in the field of antimalarial drug research and development.